Nanna Junker

Nanna Junker

Research Fellow

Followers of Nanna Junker694 followers
location of Nanna JunkerCopenhagen, Capital Region of Denmark, Denmark

Connect with Nanna Junker to Send Message

Connect

Connect with Nanna Junker to Send Message

Connect
  • Timeline

  • About me

    Experienced project manager with a strong interest in human health and drug development

  • Education

    • Københavns Universitet - University of Copenhagen

      1994 - 2000
      Master Biology
    • Københavns Universitet - University of Copenhagen

      2001 - 2004
      PhD Cancer Biology
  • Experience

    • Massachusetts General Hospital

      Jun 2001 - Jul 2002
      Research Fellow

      Cancer biology, angiogenesis and tumor micro-environment.Worked with molecular biology, transfections and cell biology

    • University of Copenhagen

      Mar 2004 - Nov 2006
      Post Doc

      Research position at The Institute of Molecular Pathology at The Faculty of HealthReserch in cancer biology with focus on tumormicroenvironment, angiogenesis and the prognostic marker YKL-40.Worked with in vitro and in vivo models and human cancer samples.Teaching General Pathology

    • The Faculty of Health Sciences at University of Copenhagen

      Nov 2006 - Aug 2011
      Assistant Professor

      Cancer research with focus on tumormicroenviroment, tumor associated macrophages and angiogenesis. Atherosclerosis research with focus on macrophage and foam cell biology under hypoxia.- Cell biology and molecular biology - Cell culture of primary cells and cancer cell lines- in vivo cancer and atherosclerosis mouse modelsTeaching General Pathology Supervision of technicians and students

    • Novo Nordisk

      Sept 2011 - Mar 2017

      Drug development within diabetic retinopathy- Evaluate and mature new targets- Evaluate in-sourcing opportunities- Engage with key opinion leaders - Anchor biology of drug targets- Support target progression experimentally with in vitro pharmacology and mode of action assays The Vascular Biology Team includes academics, technicians and students. We support drug discovery and drug development for diabetic retinopathy and cardiovascular disease with in vitro and ex vivo assays and biological expertise. Responsible for anchoring and maturing biology of targets within diabetic retinopathy and cardiovascular disease. Evalution of new targets and in-sourcing opportunitiesExperimental evalution of targets in vitro including bio assays, cell culture models, primary cell culture, mode of actions studies, ex vivo analysis, target-disease association.

      • Principal Scientist

        Oct 2015 - Mar 2017
      • Team Leader, Vascular Biology

        Jan 2014 - Oct 2015
      • Senior Scientist, Diabetic Complications Biology

        Sept 2011 - Jan 2014
    • DIS - Study Abroad

      Jan 2017 - May 2017
      External Lecturer

      Course instructor for "Diabetes, Diagnosis and Treatment" in the Science and Health program

    • Agilent Technologies

      Aug 2017 - Mar 2020
      Project Manager

      Leading cross functional medical device projects from discovery to market

    • Ferrosan Medical Devices A/S

      Apr 2020 - Dec 2022

      Leading project within innovation and life cycle management.

      • Senior Project Manager

        Oct 2022 - Dec 2022
      • Project Manager

        Apr 2020 - Oct 2022
    • Lundbeckfonden / Lundbeck Foundation

      Jan 2023 - now
      Scientific Program Manager, Frontier Grants

      Maturing basic research into commercially attractive prospects for biotech investors

  • Licenses & Certifications